{"disease":{"id":"airway-remodelling-asthmatic","name":"airway remodelling asthmatic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05651841","title":"REVErsing Airway Remodelling With Tezepelumab","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}